Latest Schedule 13G passive stakes

State Street Corporation has updated its beneficial ownership filing for Allogene Therapeutics Inc., reporting a 5.5% stake.

State Street Corporation has updated its beneficial ownership filing for Allogene Therapeutics Inc., reporting a 5.5% stake.

State Street Corporation has disclosed a beneficial ownership of 5.1% in Allegion PLC as of June 30, 2026.

State Street Corporation has disclosed a beneficial ownership of 5.1% in Allegion PLC as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.2% of Adobe Inc.'s common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.2% of Adobe Inc.'s common stock as of June 30, 2026.

The PNC Financial Services Group, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of WisdomTree U.S. LargeCap Dividend Fund shares.

State Street Corporation and SSGA Funds Management, Inc. have updated their beneficial ownership filing for ADMA Biologics Inc., reporting a combined 7.4% stake.

State Street Corporation and SSGA Funds Management, Inc. have updated their beneficial ownership filing for ADMA Biologics Inc., reporting a combined 7.4% stake.

State Street Corporation has disclosed beneficial ownership of 5.3% of Acadia Realty Trust's common stock as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.3% of Acadia Realty Trust's common stock as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for Acadia Pharmaceuticals Inc., reporting a significant holding of common stock.

State Street Corporation has updated its beneficial ownership filing for Acadia Pharmaceuticals Inc., reporting a significant holding of common stock.

The PNC Financial Services Group, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.33% in iShares Core MSCI International Developed Markets ETF.

The PNC Financial Services Group, Inc. has reported an increase in its beneficial ownership of Invesco Short Term Treasury ETF shares, now holding 6.05% of the class.

The PNC Financial Services Group, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 10.33% in the Global X Artificial Intelligence & Technology ETF.

The PNC Financial Services Group, Inc. has filed a Schedule 13G, reporting beneficial ownership of 8.13% of Cadrenal Therapeutics, Inc. common stock as of June 30, 2026.

The PNC Financial Services Group, Inc. has filed a Schedule 13G, reporting beneficial ownership of 8.13% of Cadrenal Therapeutics, Inc. common stock as of June 30, 2026.

Corebridge Financial, Inc. has disclosed a 9.2% beneficial ownership in Clearbridge Energy Midstream Opportunity Fund Inc.'s Mandatory Redeemable Preferred Stock.

Corebridge Financial, Inc. has disclosed a 9.2% beneficial ownership in Clearbridge Energy Midstream Opportunity Fund Inc.'s Mandatory Redeemable Preferred Stock.

L1 Capital Pty Ltd has increased its beneficial ownership of Anteris Technologies Global Corp. common stock to 13.46%, holding over 13.2 million shares and CDIs.

Cohen & Steers, Inc. and its affiliates have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 4.67% in PACS Group, Inc. common stock as of July 31, 2026.

Cohen & Steers entities report a combined beneficial ownership of 4.67% in CareTrust REIT, Inc. following an amendment to their Schedule 13G filing.

Cohen & Steers entities report a combined beneficial ownership of 4.67% in CareTrust REIT, Inc. following an amendment to their Schedule 13G filing.

Cohen & Steers, Inc. and its affiliates have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 4.67% in PACS Group, Inc. common stock as of July 31, 2026.

Lance Friedman has increased his beneficial ownership of Aspire Biopharma Holdings, Inc. common stock to 7.92%, holding 107,323 shares.

Several entities and an individual have filed an amendment to their Schedule 13G, confirming their beneficial ownership of Immunic, Inc. common stock.

A Schedule 13G filing confirms significant beneficial ownership stakes in Cytek Biosciences, Inc. by several entities and an individual.

Capital World Investors has reported beneficial ownership of 4,323,975 shares, representing 10.4% of Zillow Group, Inc.'s common stock.

Capital World Investors has updated its beneficial ownership filing for Zillow Group, Inc., reporting a 4.9% stake.